Status:

UNKNOWN

Dose Escalation to Dominant Intraprostatic Lesions (DIL) With MRI-TRUS Fusion High Dose Rate (HDR) Prostate Brachytherapy

Lead Sponsor:

Alfonso Gomez-Iturriaga

Collaborating Sponsors:

Hospital de Cruces

Conditions:

Prostate Cancer

Eligibility:

MALE

18+ years

Phase:

PHASE2

Brief Summary

The Magnetic Resonance (MR) provides high resolution of soft tissue images allowing an appropriate assessment of the local extent of the disease. Recent studies have shown an increase in sensitivity a...

Detailed Description

Treatment: The patient's treatment will consist of combined Hypofractionated external beam (3750 cGray in 15 fractions) and MRI-TRUS fusion HDR brachytherapy boost (1 fraction of 1500 cGray. Brachyt...

Eligibility Criteria

Inclusion

  • Men ≥18 years
  • Histologically proven adenocarcinoma of the prostate
  • Intermediate or high risk prostate cancer
  • Intermediate risk prostate cancer patients must have:
  • Clinical stage ≤ T2c, Gleason score = 7 and iPSA ≤ 20, or Gleason score ≤ 6 and iPSA \> 10 and ≤ 20. High risk patients may have Clinical stage T3 Gleason score 8-10 PSA \> 20 ng/ml
  • A palpable nodule or a cluster of positive biopsies from a single region suggesting the presence of dominant nodule and with radiologic correlation by MRI.
  • Estimated life expectancy of at least 10 years.
  • ECOG performance status of 0 - 2.
  • Signature of informed conseny

Exclusion

  • Contraindications to interstitial prostate brachytherapy.
  • If on coumadin therapy and NOT able to stop safely for 7 days.
  • Does not have a localized high volume of intraprostatic disease and MRI contraindicated
  • Unfit for general anesthetic

Key Trial Info

Start Date :

June 1 2013

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

July 1 2016

Estimated Enrollment :

15 Patients enrolled

Trial Details

Trial ID

NCT01909388

Start Date

June 1 2013

End Date

July 1 2016

Last Update

July 26 2013

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Hospital Universitario Cruces

Barakaldo, Bizkaia, Spain, 48903